NEW YORK (GenomeWeb News) – Shares of PerkinElmer were up 5 percent in late Thursday afternoon trade on the New York Stock Exchange after investment bank Thomas Weisel Partners upgraded the firm's stock to "overweight" from "market weight."

Peter Lawson, an analyst for the bank, also raised his price target on PerkinElmer's shares to $20 from his previous target of $18.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.